Outset Medical, previously Home Dialysis Plus, said it raised $91 million in a new funding round, with $51 million in equity and $40 million in debt funding. Funds are slated to continue development and promotion of its Tablo all-in-one dialysis system.
The $51 million round of equity funding was led by new investor Fidelity Research and Management Co., joined by new investors Partner Fund Management LP, Perceptive Advisors and CRG, and prior backers Warburg Pincus and The Vertical Group, Outset Medical said. The $40 million in debt financing was led by CRG.
Last month, San Jose, Calif.-based Outset Medical said in a regulatory filing that it raised $60 million from 9 unnamed investors as it pursued funds to develop its Tablo system.
The Tablo system is designed to be an all-in-one dialysis machine, handling water purification and dialysate production, CEO Leslie Trigg told MassDevice.com. The system comes with a touch-screen interface that allows patients or providers to operate the platform.
Read More: http://www.massdevice.com/update-outset-medical-raises-91m-for-all-in-one-dialysis-system/
Via: Mass Device